Showing results (101-110 of 243) with videos related to
Sort By:
Pageof 25
International Journal of Clinical Oncology|May 12, 2023
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective studyShinji Nakamichi, Kaoru Kubota, Fenfei Zou, et al.Radiology Case Reports|April 22, 2024
Interstitial lung disease with prolonged fever that occurred during long-term administration of olaparib in a 74-year-old ovarian cancer patient: Radiological features and considerations for preventing delayed diagnosisYoshinobu Saito, Rei Yamaguchi, Takahiro Suzuki, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|April 11, 2022
Effectiveness of Corticosteroid Therapy for Non-Severe COVID-19 in Patients Not Requiring Supplemental Oxygen Who Have Risk Factors for Severe DiseaseToru Tanaka, Yoshinobu Saito, Takeru Kashiwada, et al.Translational Lung Cancer Research|September 15, 2025
Effect of type 2 diabetes mellitus on systemic treatment for advanced non-small cell lung cancerYasuhiro Kato, Eri Kuramochi, Rei Yamaguchi, et al.Internal Medicine (Tokyo, Japan)|July 3, 2024
Streptococcal Toxic Shock Syndrome with Multiple Cerebral Infarctions Caused by Streptococcus dysgalactiae subsp. equisimilis: An Autopsy Case ReportSho Saito, Namiko Taniuchi, Norio Motoda, et al.Cancer Science|April 14, 2010
Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expressionRintaro Noro, Akihiko Miyanaga, Yuji Minegishi, et al.BMC Pulmonary Medicine|December 19, 2024
Bortezomib induces Rho-dependent hyperpermeability of endothelial cells synergistically with inflammatory mediatorsShunichi Nishima, Takeru Kashiwada, Yoshinobu Saito, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 7, 2024
A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung CancerSatoru Matsuki, Namiko Taniuchi, Naoko Okada, et al.JTO Clinical and Research Reports|October 27, 2023
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLCYuto Terashima, Masaru Matsumoto, Hiroki Iida, et al.Molecular Cancer Therapeutics|November 22, 2013
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cellsKazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al.Pageof 25